Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide Riboside on Immunity
NCT02812238Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jun 2016
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by National Heart, Lung, and Blood Institute. Primary endpoint: Mean IL-1 Beta Release From Peripheral Blood Mononuclear Cells During Refeeding After 24 Hour Fast. Started Jun 2016; status: completed.
Beyond the preview
Go deeper on NCT02812238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02812238.